Introduction: Coronavirus disease 2019 (COVID-19) is a systemic disease characterized by
a disproportionate inflammatory response in the acute phase. This study sought to identify …

Emerging evidence indicates that the etiologic agent responsible for coronavirus disease
2019 (COVID-19), can cause neurological complications. COVID-19 may induce cognitive …

Background Long-COVID diagnosis is prominent, and our attention must support those
experiencing debilitating and long-standing symptoms. To establish patient pathways, we …

INTRODUCTION: The coronavirus disease (COVID-19) continues to affect many countries
globally, with the long-term impact of the disease now being recognized. According to the …

Since the initial reports of coronavirus disease 2019 (COVID-19) in China in late 2019,
infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have …

Background and purpose To assess neurological manifestations and health‐related quality
of life (QoL) 3 months after COVID‐19. Methods In this prospective, multicenter …

Background: A previous study has shown that 81% of the COVID-19 patients had mild or
moderate symptoms. However, most studies on the sequelae in COVID-19 patients focused …

Rationale: Data on longitudinal recovery after hospitalization for coronavirus disease
(COVID-19) currently remain scarce, just as outcomes beyond 3 months of follow-up do …

Background The long-term pulmonary function and related physiological characteristics of
COVID-19 survivors have not been studied in depth, thus many aspects are not understood …

The long-term pulmonary outcomes of coronavirus disease 2019 (COVID-19) are unknown.
We aimed to describe self-reported dyspnoea, quality of life, pulmonary function and chest …